Skip to content

Stress Testing

Exercise is preferred when the patient can exercise safely. It provides functional capacity, symptoms, ECG changes, blood-pressure response, and arrhythmia assessment.

Choosing the Stressor

Situation Stress method
Can exercise adequately Exercise
Cannot exercise Pharmacologic
LBBB or ventricular pacing Vasodilator stress
Active wheezing or bronchospasm Avoid vasodilators; consider dobutamine
Cannot exercise or receive a vasodilator Dobutamine

Note

Reaching 85% of age-predicted maximal heart rate is not an automatic stopping point. Continue until maximal effort, limiting symptoms, or another termination criterion.

Exercise ECG

Exercise ECG is appropriate when the patient can exercise and the baseline ECG is interpretable.

Add imaging for:

  • LBBB
  • Ventricular pacing
  • Pre-excitation
  • Resting ST depression ≥1 mm
  • Digoxin-related ST changes
  • Marked LVH with repolarization abnormality

RBBB alone does not make the ECG uninterpretable, although V1–V3 are unreliable for ischemia assessment.

Positive ECG Response

  • ≥1 mm horizontal or downsloping ST depression
  • Measured approximately 60–80 ms after the J point
  • Occurring during exercise or recovery

New ST elevation ≥1 mm in a lead without a prior Q wave is a high-risk finding.

Duke Treadmill Score

\[ \text{DTS} = \text{exercise time} - 5(\text{ST deviation}) - 4(\text{angina index}) \]

Angina index:

  • 0 = none
  • 1 = nonlimiting
  • 2 = exercise-limiting
Score Risk
≥5 Low
−10 to +4 Intermediate
≤−11 High

High-Risk Findings

  • Exercise capacity <5 METs
  • Ischemia at a low workload
  • ≥2 mm ST depression
  • ST depression persisting into recovery
  • Exercise-induced ST elevation
  • Fall in systolic blood pressure
  • Limiting angina
  • Ventricular tachycardia
  • Abnormal heart-rate recovery

Achieving ≥10 METs without high-risk findings generally predicts a favorable prognosis.

Do Not Exercise

  • Acute MI within approximately 2 days
  • Ongoing unstable angina or ACS
  • Hemodynamically significant arrhythmia
  • Symptomatic severe aortic stenosis
  • Decompensated heart failure
  • Acute pulmonary embolism
  • Acute myocarditis or pericarditis
  • Acute aortic dissection

Stop the Test For

  • Moderate-to-severe angina
  • Sustained ventricular tachycardia
  • Signs of poor perfusion
  • Neurologic symptoms
  • Ischemic ST elevation
  • SBP decrease >10 mm Hg with ischemia
  • Inability to monitor ECG or blood pressure
  • Patient request

Pharmacologic Stress

Agent Mechanism Important point
Adenosine Nonselective adenosine agonist Very short half-life
Dipyridamole Increases endogenous adenosine Longer duration
Regadenoson Selective A2A agonist Fixed 0.4-mg IV dose
Dobutamine β1-mediated inotropy and chronotropy Increases myocardial demand

Avoid Vasodilators With

  • Active wheezing or bronchospasm
  • High-grade AV block without a pacemaker
  • Sinus-node dysfunction without a pacemaker
  • SBP <90 mm Hg
  • Unstable ACS
  • Recent caffeine or methylxanthine exposure
  • Dipyridamole use within approximately 48 hours

Aminophylline can reverse serious vasodilator effects but should not be used for a regadenoson-associated seizure.

Board Pearls

  • LBBB or ventricular pacing → vasodilator MPI
  • Active wheezing + unable to exercise → consider dobutamine
  • Exercise is preferred even when imaging is required
  • Caffeine can invalidate vasodilator stress
  • Regadenoson-related dyspnea does not necessarily mean bronchospasm
  • Interpret symptoms, workload, ECG, hemodynamics, and imaging together

References